JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.
Huppke, Peter
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity. [electronic resource] - Multiple sclerosis (Houndmills, Basingstoke, England) Apr 2015 - 382-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1477-0970
10.1177/1352458514543340 doi
Adolescent
Antibodies, Viral--blood
Child
Cohort Studies
Female
Humans
Immunologic Factors--therapeutic use
JC Virus
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Natalizumab--therapeutic use
Polyomavirus Infections--epidemiology
Prevalence
Seroconversion
Seroepidemiologic Studies
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity. [electronic resource] - Multiple sclerosis (Houndmills, Basingstoke, England) Apr 2015 - 382-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1477-0970
10.1177/1352458514543340 doi
Adolescent
Antibodies, Viral--blood
Child
Cohort Studies
Female
Humans
Immunologic Factors--therapeutic use
JC Virus
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Natalizumab--therapeutic use
Polyomavirus Infections--epidemiology
Prevalence
Seroconversion
Seroepidemiologic Studies